{"entity":{"id":"roman-rouzier","kind":"person","name":"Roman Rouzier","aka":[],"tldr":"Gynaecological and breast surgeon who has directed Centre François Baclesse, the comprehensive cancer centre for Normandy in Caen, since July 2023.","summary":"Professeur Roman Rouzier has been Directeur Général of Centre François Baclesse since 1 July 2023. He is a gynaecological surgeon specialising in breast surgery. The centre's organisation page states that he is supported by Michael Canovas, Directeur Général Adjoint. Centre François Baclesse is the Centre de Lutte Contre le Cancer for Normandy, based in Caen, providing cancer treatment, research and training within the Unicancer network.","asOf":"2026-09-10","links":[{"label":"Source: Centre François Baclesse organisation page","url":"https://www.baclesse.fr/decouvrir-le-centre/organisation/"}],"tags":["leadership","clinician-scientist","comprehensive-cancer-centre"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["centre-francois-baclesse"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["european-journal-of-cancer","journal-of-cancer-policy"],"dependsOn":[],"notes":[],"role":"Directeur Général (Director General), Centre François Baclesse","institutionId":"centre-francois-baclesse","specialisms":["Gynaecological surgery","Breast surgery","Cancer centre management"],"profiles":[{"label":"Centre François Baclesse organisation page","url":"https://www.baclesse.fr/decouvrir-le-centre/organisation/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Rouzier+R%5BAuthor%5D"}],"papers":[{"title":"Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial","journal":"European Journal of Cancer","year":2017,"doi":"10.1016/j.ejca.2016.09.036"},{"title":"Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis","journal":"Frontiers in Oncology","year":2023,"doi":"10.3389/fonc.2023.1191943"},{"title":"Current perspectives for external control arms in oncology clinical trials: Analysis of EMA approvals 2016–2021","journal":"Journal of Cancer Policy","year":2023,"doi":"10.1016/j.jcpo.2023.100403"}]},"route":"/people/roman-rouzier/","neighbours":{"institution":[{"id":"centre-francois-baclesse","kind":"institution","name":"Centre François Baclesse","route":"/institutions/centre-francois-baclesse/"}],"journal":[{"id":"european-journal-of-cancer","kind":"journal","name":"European Journal of Cancer","route":"/journals/european-journal-of-cancer/"},{"id":"journal-of-cancer-policy","kind":"journal","name":"Journal of cancer policy","route":"/journals/journal-of-cancer-policy/"}]}}